The first Novartis AG trade was made in Q4 2023. Since then Jefferies Group bought shares one more times and sold shares on two occasions. The investor sold all their shares in Q1 2026 and doesn't own any shares in Novartis AG anymore.
… , and multiple sclerosis4-8. Novartis will submit remibrutinib for approval … effective oral option within the Novartis immunology portfolio, which current...
Sandoz is a global leader in the generics and biosimilars sector. Click here to read why I think spinning off SDZNY stock was a good move by Novartis.
LEIDEN, Netherlands , April 11, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commerci...
APDS (activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome) is a rare and progressive primary immunodeficiency Joenja® is a targeted treatment of APDS ...